Xiaoguang Wang

18PUBLICATIONS
27CO-AUTHORS
Molecular targetsHaematological tumoursPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Aug 20, 2026
Tumor-derived PTX3 drives an immunosuppressive myeloid landscape and inhibits CD8 T cell-mediated anti-tumor immunity via PI3K-dependent signaling.

|Mar 05, 2026
Preexisting TCR Clones Drive Major Pathologic Responses in Patients with HNSCC Treated with Dual Immune Checkpoint Inhibitors.

Huaibin Ge, Housaiyin Li, Aditi Kulkarni

|Nov 27, 2024
Targeting Myeloid Cells in Head and Neck Squamous Cell Carcinoma: A Kinase Inhibitor Library Screening Approach.

Mohamed Y Zaky, Jessy John, Monika Vashisht

|Sep 07, 2023
TRAF2/3 deficient B cells resist DNA damage-induced apoptosis via NF-κB2/XIAP/cIAP2 axis and IAP antagonist sensitizes mutant lymphomas to chemotherapeutic drugs.

Monika Vashisht, Huaibin Ge, Jessy John

|Apr 08, 2023
Pharmacologic targeting of Nedd8-activating enzyme reinvigorates T-cell responses in lymphoid neoplasia.

Xiaoguang Wang, Canping Chen, Dan Vuong

|Feb 13, 2023
FAK loss reduces BRAFV600E-induced ERK phosphorylation to promote intestinal stemness and cecal tumor formation.

Chenxi Gao, Huaibin Ge, Shih-Fan Kuan

Pageof 3

Frequent Collaborators

2 joint publications

Zhangguo Chen

2 joint publications

Xiao-Jing Wang

2 joint publications

Robert L Ferris

2 joint publications

Huaibin Ge